These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

950 related articles for article (PubMed ID: 33215460)

  • 1. Expressions of SAA, CRP, and FERR in different severities of COVID-19.
    Liu SL; Wang SY; Sun YF; Jia QY; Yang CL; Cai PJ; Li JY; Wang L; Chen Y
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11386-11394. PubMed ID: 33215460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.
    Li H; Xiang X; Ren H; Xu L; Zhao L; Chen X; Long H; Wang Q; Wu Q
    J Infect; 2020 Jun; 80(6):646-655. PubMed ID: 32277967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of serum amyloid A in patients with COVID-19.
    Cheng L; Yang JZ; Bai WH; Li ZY; Sun LF; Yan JJ; Zhou CL; Tang BP
    Infection; 2020 Oct; 48(5):715-722. PubMed ID: 32734556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of organ function in patients with severe COVID-19 infections.
    Zhu Y; Du Z; Zhu Y; Li W; Miao H; Li Z
    Med Clin (Barc); 2020 Sep; 155(5):191-196. PubMed ID: 32586669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and the risk factors for severe events of elderly coronavirus disease 2019 patients.
    Wang G; Wu C; Zhang Q; Yu B; LÜ J; Zhang S; Wu G; Wu Y; Zhong Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):542-548. PubMed ID: 32879104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of viral load with serum biomakers among COVID-19 cases.
    Shi F; Wu T; Zhu X; Ge Y; Zeng X; Chi Y; Du X; Zhu L; Zhu F; Zhu B; Cui L; Wu B
    Virology; 2020 Jul; 546():122-126. PubMed ID: 32452410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
    Yang M; Chen X; Xu Y
    Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
    Tan C; Huang Y; Shi F; Tan K; Ma Q; Chen Y; Jiang X; Li X
    J Med Virol; 2020 Jul; 92(7):856-862. PubMed ID: 32281668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
    Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution of acute-phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19).
    Li L; Chen C
    Epidemiol Infect; 2020 Jul; 148():e164. PubMed ID: 32713370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study.
    Yu Y; Liu T; Shao L; Li X; He CK; Jamal M; Luo Y; Wang Y; Liu Y; Shang Y; Pan Y; Wang X; Zhou F
    Virulence; 2020 Dec; 11(1):1569-1581. PubMed ID: 33172355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: association with clinical and laboratory data.
    Gatti M; Calandri M; Barba M; Biondo A; Geninatti C; Gentile S; Greco M; Morrone V; Piatti C; Santonocito A; Varello S; Bergamasco L; Cavallo R; Di Stefano R; Riccardini F; Boccuzzi A; Limerutti G; Veltri A; Fonio P; Faletti R
    Radiol Med; 2020 Dec; 125(12):1271-1279. PubMed ID: 32894449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.
    Wang S; Ma P; Zhang S; Song S; Wang Z; Ma Y; Xu J; Wu F; Duan L; Yin Z; Luo H; Xiong N; Xu M; Zeng T; Jin Y
    Diabetologia; 2020 Oct; 63(10):2102-2111. PubMed ID: 32647915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver damage at admission is an independent prognostic factor for COVID-19.
    Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
    J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.